Short Communication: Reduced Nevirapine Concentrations Among HIV-Positive Women Receiving Mefloquine for Intermittent Preventive Treatment for Malaria Control During Pregnancy

Clinical trials demonstrated intermittent preventive treatment in pregnancy with mefloquine (MQ) reduced malaria rates among pregnant women, yet an unexpected higher risk of mother-to-child transmission (MTCT) of HIV among HIV-positive women receiving MQ has also been observed. To determine if inter...

Descripción completa

Detalles Bibliográficos
Autores principales: Haaland, Richard E., Otieno, Kephas, Martin, Amy, Katana, Abraham, Dinh, Chuong, Slutsker, Laurence, Menendez, Clara, Gonzalez, Raquel, Williamson, John, Heneine, Walid, Desai, Meghna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2018
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238614/
https://www.ncbi.nlm.nih.gov/pubmed/30173559
http://dx.doi.org/10.1089/aid.2018.0042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238614/
https://www.ncbi.nlm.nih.gov/pubmed/30173559
http://dx.doi.org/10.1089/aid.2018.0042

Ejemplares similares